Studies have shown that disruption of Smo/Gli-1 signaling increases chemosensitivity through downregulation of IGF-1R/Akt/MRP1 pathway and transcriptional control of twist1 and snail in AML cells [42, 64]. This evidence concerns the gene GLI1 and acute myeloid leukemia.